Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis

Universa Medicina · Vol. 35 No. 1 (2016) · hlm. 26–32

DOI
10.18051/UnivMed.2016.v35.26-32
ISSN
2407-2230, 1907-3062
Terbit
2016-05-09
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng

Abstrak

BackgroundChronic hepatitis and hepatic cirrhosis are chronic liver diseases that cause disorders of liver function, such as the formation of platelets and coagulation factors (prothrombin time/PT and activated partial thromboplastin time/APTT). Chronic hepatitis in the long term can develop into hepatic cirrhosis. The aim of this study was to determine platelet count, PT, and APTT as indicators in the progression of chronic hepatitis towards hepatic cirrhosis. MethodsA cross-sectional study was conducted on 50 patients with chronic hepatitis and hepatic cirrhosis in Semarang City Regional General Hospital, Telogorejo Hospital and Kariadi General Hospital. The platelet count was measured with a Sysmex XP-100, while PT and APTT was measured with a Sysmex CA-1500 coagulometer. The Mann Whitney test was applied to analyze the difference in platelet count, PT, and APTT between chronic hepatitis and hepatic cirrhosis. Results Median, minimum, and maximum values of platelet count, PT and APTT in chronic hepatitis were 284.000/µl, 210.000/µl, 390.000/µl; 10.6 sec, 9.5 sec, 13.6 sec; and 30.5 sec, 24.2 sec, 46.4 sec, respectively, and in hepatic cirrhosis they were 96.300/µl, 48.200/µl, 133.800/µl; 27.5 sec, 11.9 sec, 44.7 sec; and 55.6 sec, 31.3 sec, 72.0 sec, respectively. There was a significant difference the reduction of platelet count, and the prolongation of PT and APTT in chronic hepatitis compared to hepatic cirrhosis (p=0.000). ConclusionsProthrombine time and APTT were prolonged and platelet count was decreased in hepatic cirrhosis subjects. The three parameters may be used to evaluate the progression of chronic hepatitis towards hepatic cirrhosis.

Kata kunci

Jaringan kolaborasi para penulis

19 penulis · 38 tautan kepenulisan bersama · 12 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Universitas Jambi
  • Bandung Institute of Technology
  • University of KwaZulu-Natal
  • Universitas Muhammadiyah Semarang
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Kis DjamiatunDiponegoro University1
Ibrahem Omran LakhderDiponegoro University1
Meita HendrianingtyasDiponegoro University1
Ajeng Kurnia WardhaniDiponegoro University1
Indranila Kustarini SamsuriaDiponegoro University1
Ria TriwardhaniDiponegoro University1
Yuliana YulianaUniversitas Jambi1
Dwi RetnoningrumDiponegoro University1
Nyoman Suci WidyastitiDiponegoro University1
Purwanto AdipirenoDiponegoro University1
Nuning NurainiBandung Institute of Technology1
Sutimin SutiminDiponegoro University1
Faraimunashe ChiroveUniversity of KwaZulu-Natal1
Hertanto Wahyu SubagioDiponegoro University1
Budi SantosoUniversitas Muhammadiyah Semarang1
Henna Rya SunomoDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis</dc:title>
	<dc:creator xml:lang="en">Limijadi, Edward Kurnia Setiawan</dc:creator>
	<dc:creator xml:lang="en">Suromo, Lisyani Budi</dc:creator>
	<dc:creator xml:lang="en">Budiwiyono, Imam</dc:creator>
	<dc:subject xml:lang="en">Platelet count</dc:subject>
	<dc:subject xml:lang="en">PT</dc:subject>
	<dc:subject xml:lang="en">APTT</dc:subject>
	<dc:subject xml:lang="en">chronic hepatitis</dc:subject>
	<dc:subject xml:lang="en">hepatic cirrhosis</dc:subject>
	<dc:description xml:lang="en">BackgroundChronic hepatitis and hepatic cirrhosis are chronic liver diseases that cause disorders of liver function, such as the formation of platelets and coagulation factors (prothrombin time/PT and activated partial thromboplastin time/APTT). Chronic hepatitis in the long term can develop into hepatic cirrhosis. The aim of this study was to determine platelet count, PT, and APTT as indicators in the progression of chronic hepatitis towards hepatic cirrhosis. MethodsA cross-sectional study was conducted on 50 patients with chronic hepatitis and hepatic cirrhosis in Semarang City Regional General Hospital, Telogorejo Hospital and Kariadi General Hospital. The platelet count was measured with a Sysmex XP-100, while PT and APTT was measured with a Sysmex CA-1500 coagulometer. The Mann Whitney test was applied to analyze the difference in platelet count, PT, and APTT between chronic hepatitis and hepatic cirrhosis. Results Median, minimum, and maximum values of platelet count, PT and APTT in chronic hepatitis were 284.000/µl, 210.000/µl, 390.000/µl; 10.6 sec, 9.5 sec, 13.6 sec; and 30.5 sec, 24.2 sec, 46.4 sec, respectively, and in hepatic cirrhosis they were 96.300/µl, 48.200/µl, 133.800/µl; 27.5 sec, 11.9 sec, 44.7 sec; and 55.6 sec, 31.3 sec, 72.0 sec, respectively. There was a significant difference the reduction of platelet count, and the prolongation of PT and APTT in chronic hepatitis compared to hepatic cirrhosis (p=0.000). ConclusionsProthrombine time and APTT were prolonged and platelet count was decreased in hepatic cirrhosis subjects. The three parameters may be used to evaluate the progression of chronic hepatitis towards hepatic cirrhosis.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2016-05-09</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/220</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2016.v35.26-32</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 35 No. 1 (2016); 26-32</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:source>10.18051/UnivMed.2016.v35.i1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/220/396</dc:relation>
	<dc:relation>10.18051/univmed.v35i1.220</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2016 Edward Kurnia Setiawan Limijadi, Lisyani Budi Suromo, Imam Budiwiyono</dc:rights>
</oai_dc:dc>